Scholarlink

The use of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) PET permited a more sensitive assessment of metabolically active tumor, treatment failure, and distant non-contrast-enhancing progression in this patient with anaplastic oligodendroglioma, WHO grade III, where progression on MRI was challenged because of changing patterns of speckled new and dissolving old non-measurable contrast enhancement.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Case 39: Progressive Glioma

  • 章节

  • 发表日期：

    2025年

查看全文
  • Ian Law,
  • Jonathan F. Carlsen,
  • Benedikte Hasselbalch

摘要

The use of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) PET permited a more sensitive assessment of metabolically active tumor, treatment failure, and distant non-contrast-enhancing progression in this patient with anaplastic oligodendroglioma, WHO grade III, where progression on MRI was challenged because of changing patterns of speckled new and dissolving old non-measurable contrast enhancement.